Apogee Therapeutics, Inc.
APGE
Revenue
0.00
0.000.00%
-Assets
714.16M
▼-39.79M▼-5.28%
3 Months ChangeLiabilities
40.80M
▲3.64M▲9.80%
3 Months ChangeFree Cash Flow
-52.79M
▼-20.81M▼-65.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-24
Form 8-K
ID: 0001104659-24-111027
2024-08-19
Form 8-K
ID: 0001104659-24-090690
2024-08-12
Form 10-Q
ID: 0000950170-24-095053
2024-08-12
Form 8-K
ID: 0001104659-24-088029
2024-06-07
Form 8-K
ID: 0001104659-24-069619
2024-05-28
Form 8-K
ID: 0001104659-24-065322
2024-05-15
Form 8-K
ID: 0001104659-24-061998
2024-05-13
Form 10-Q
ID: 0001558370-24-007861
2024-05-13
Form 8-K
ID: 0001104659-24-060195
2024-03-25
Form 8-K
ID: 0001104659-24-038161